Actinium Pharmaceuticals Inc. (NYSE American: ATNM) announced it will present preclinical data on two of its drug candidates at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE